# Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease

> **NCT01715350** · PHASE2 · COMPLETED · sponsor: **VTBIO Co. LTD** · enrollment: 151 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** PM012
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01715350
- **Lead sponsor:** VTBIO Co. LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-09
- **Final completion:** 2015-06
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2016-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01715350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01715350, "Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01715350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*